"Mutation Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of mutations that occur in a specific sequence, GENE, or GENOME over a specified period of time such as years, CELL DIVISIONS, or generations.
Descriptor ID |
D059645
|
MeSH Number(s) |
G05.045.250.750 G05.365.590.612 G16.075.250.750
|
Concept/Terms |
Mutation Rate- Mutation Rate
- Mutation Rates
- Rate, Mutation
- Rates, Mutation
- Mutation Frequency
- Frequencies, Mutation
- Frequency, Mutation
- Mutation Frequencies
|
Below are MeSH descriptors whose meaning is more general than "Mutation Rate".
Below are MeSH descriptors whose meaning is more specific than "Mutation Rate".
This graph shows the total number of publications written about "Mutation Rate" by people in this website by year, and whether "Mutation Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 0 | 1 | 1 |
2014 | 1 | 2 | 3 |
2016 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation Rate" by people in Profiles.
-
Low Frequency of Protease Inhibitor Resistance Mutations and Insertions in HIV-1 Subtype C Protease Inhibitor-Naïve Sequences. AIDS Res Hum Retroviruses. 2019 07; 35(7):673-678.
-
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018 04; 177(3):346-357.
-
Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible? Virol J. 2016 10 12; 13(1):170.
-
Hepatitis B virus subgenotype A1: evolutionary relationships between Brazilian, African and Asian isolates. PLoS One. 2014; 9(8):e105317.
-
Drug susceptibility and resistance mutations after first-line failure in resource limited settings. Clin Infect Dis. 2014 Sep 01; 59(5):706-15.
-
Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort. Int J Lab Hematol. 2014 Dec; 36(6):656-64.
-
The contribution of Nth and Nei DNA glycosylases to mutagenesis in Mycobacterium smegmatis. DNA Repair (Amst). 2014 Jan; 13:32-41.